MTOR and breast cancer: Quantitative analysis revealed that the ratios of p-mTOR/mTOR, p-Akt/Akt, p-p70S6K/p70S6K, and p-4EBP1/4EBP1 were significantly reduced upon pegaspargase treatment in a concentration-dependent fashion (Fig. 5A and BC).